**Question:** Apixaban is classified as

A. Direct oral anticoagulant (DOAC)
B. Non-steroidal anti-inflammatory drug (NSAID)
C. Angiotensin-converting enzyme (ACE) inhibitor
D. Calcium channel blocker

**Correct Answer:** Apixaban is classified as a **Direct oral anticoagulant (DOAC)**.

**Core Concept:** Apixaban is a direct oral anticoagulant (DOAC) that belongs to the class of drugs called vitamin K antagonists, specifically, a direct factor Xa inhibitor. This class of drugs is used for the prevention and treatment of blood clots, reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF), deep vein thrombosis (DVT), and pulmonary embolism (PE).

**Why the Correct Answer is Right:** Apixaban is a direct factor Xa inhibitor, inhibiting the activation of factor Xa, a key enzyme involved in the intrinsic pathway of the coagulation cascade. This results in reduced thrombin generation and ultimately prevents clot formation and growth. By inhibiting factor Xa, apixaban prevents the formation of thrombin and fibrin, which are essential for clot formation.

**Why Each Wrong Option is Incorrect:**

A. **Direct oral anticoagulant (DOAC)** - Although apixaban is a DOAC, option A is incorrect because it is not mentioning the specific mechanism of action (inhibiting factor Xa) and the context (prevention and treatment of blood clots).

B. **Non-steroidal anti-inflammatory drug (NSAID)** - Apixaban is not a NSAID, which are a class of drugs used primarily for pain relief, inflammation, and fever reduction.

C. **Angiotensin-converting enzyme (ACE) inhibitor** - Apixaban is not an ACE inhibitor, which are a class of drugs used to lower blood pressure and treat heart failure. Apixaban works through a different mechanism.

D. **Calcium channel blocker** - Apixaban is not a calcium channel blocker, which are drugs used for hypertension and angina by blocking calcium channels in cardiac myocytes. Apixaban works through a different mechanism.

**Clinical Pearl:** Understanding the pharmacological action of apixaban is crucial for the appropriate use of this medication in preventing and treating thrombotic disorders like atrial fibrillation, deep vein thrombosis, and pulmonary embolism. By understanding its mechanism of action, healthcare professionals can ensure safe and effective treatment for their patients.